NewAmsterdam Pharma NAMS
$18.41 −$1.10 (-5.64%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $18.32 -0.49%
Open$19.21
Prev close$19.51
Day range$18.29 – $19.78
Volume1.75M
Market cap$2.21B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts10
Average target$54.44+195.7% vs. price
- Buy 100%
Low $42.00Now $18.41Avg $54.44High $61.00
Recent rating changes
The last 20 actions on file set price targets from $42.00 to $61.00, averaging $52.88.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | Cantor Fitzgerald | BUY | $61.00 |
| 9 Nov 2026 | Piper Sandler | BUY | $60.00 |
| 9 Nov 2026 | Stifel | BUY | $50.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $52.00 |
| 5 Nov 2026 | Wells Fargo | BUY | $55.00 |
| 5 Nov 2026 | BMO Capital | BUY | $58.00 |
| 4 Nov 2026 | RBC Capital | BUY | $42.00 |
| 15 Oct 2026 | Citi | BUY | $55.00 |
| 5 Oct 2026 | RBC Capital | BUY | $42.00 |
| 2 Oct 2026 | Wells Fargo | BUY | $55.00 |
| 29 Sep 2026 | H.C. Wainwright | BUY | $52.00 |
| 22 Sep 2026 | Truist Financial | BUY | $57.00 |
| 21 Sep 2026 | BMO Capital | BUY | $58.00 |
| 21 Sep 2026 | H.C. Wainwright | BUY | $52.00 |
| 18 Sep 2026 | William Blair | BUY | – |
| 8 Sep 2026 | Truist Financial | BUY | – |
| 8 Sep 2026 | Stifel | BUY | $50.00 |
| 8 Sep 2026 | H.C. Wainwright | BUY | $52.00 |
| 7 Aug 2026 | Needham | BUY | $48.00 |
| 6 Aug 2026 | Truist Financial | BUY | – |
No comments yet — be the first to weigh in on NAMS.
Sign in to join the discussion.